Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORIVER: Ivermectin as antiviral treatment for ambulatory COVID-19 patients
2020-001971-33Phase 3Active
- Sponsor
- Carmen Hidalgo
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Carmen Hidalgo. Primary endpoints: Clinical cure, Microbiological response and 1 more. Started Jul 2020; status: active.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001971-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001971-33.